Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
2015 · Journal of Translational Medicine · 109 citations
https://doi.org/10.1186/s12967-015-0581-2
M
Min Pan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
1.3K
Citations
17
h-index
18
i10-index
Min Pan is an academic researcher from Guangzhou University of Chinese Medicine. The author has contributed to research in topics: Neuroblastoma Research and Treatments & Epigenetics and DNA Methylation & Single-cell and spatial transcriptomics. The author has an h-index of 17, co-authored 37 publications.
ORCID: 0000-0002-9338-8491Papers by this author
worksA CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeutics
2023 · Nature Communications · 20 citations
https://doi.org/10.1038/s41467-023-43134-0
An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programs
2024 · Genome biology · 19 citations
https://doi.org/10.1186/s13059-024-03309-4
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid
2025 · Nature Communications · 3 citations
https://doi.org/10.1038/s41467-025-57185-y
LRP5 enhances glioma cell proliferation by modulating the MAPK/p53/cdc2 pathway
2025 · International Journal of Medical Sciences · 2 citations
https://doi.org/10.7150/ijms.99920
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat